Co-Diagnostics, Inc. General and Administrative Expense
Co-Diagnostics, Inc. (CODX) reported General and Administrative Expense of $1.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2026-08-13
- Co-Diagnostics, Inc. general and administrative expense for the quarter ending 2026-06-30 was $1.50M, a 42.28% decline year-over-year.
- Co-Diagnostics, Inc. general and administrative expense for the quarter ending 2026-03-31 was $2.50M, a 9.74% decline year-over-year.
- Co-Diagnostics, Inc. general and administrative expense for the quarter ending 2025-12-31 was $1.87M, a 67.88% decline year-over-year.
- Co-Diagnostics, Inc. general and administrative expense for the quarter ending 2025-09-30 was $1.82M, a 57.64% decline year-over-year.
- Co-Diagnostics, Inc. general and administrative expense for fiscal 2025 was $9.06M, a 43.94% decline from fiscal 2024.
- Co-Diagnostics, Inc. general and administrative expense for fiscal 2024 was $16.16M, a 13.15% increase from fiscal 2023.
- Co-Diagnostics, Inc. general and administrative expense for fiscal 2023 was $14.28M, a 0.12% increase from fiscal 2022.
- Co-Diagnostics, Inc. general and administrative expense for fiscal 2022 was $14.26M, a 23.48% increase from fiscal 2021.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.50M 10-Q · filed 2026-08-13 | $4.00M 10-Q · filed 2026-08-13 | $5.87M derived: sum of 3 quarters · filed 2026-08-13 | $7.69M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $2.50M 10-Q · filed 2026-05-14 | $4.37M derived: sum of 2 quarters · filed 2026-05-14 | $6.19M derived: sum of 3 quarters · filed 2026-05-14 | $8.79M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $3.69M derived: sum of 2 quarters · filed 2026-03-31 | $6.29M derived: sum of 3 quarters · filed 2026-08-13 | $9.06M 10-K · filed 2026-03-31 |
| 2025-09-30 | $1.82M 10-Q · filed 2025-11-13 | $4.42M derived: sum of 2 quarters · filed 2026-08-13 | $7.19M 10-Q · filed 2025-11-13 | $13.01M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $2.60M 10-Q · filed 2026-08-13 | $5.37M 10-Q · filed 2026-08-13 | $11.19M derived: sum of 3 quarters · filed 2026-08-13 | $15.48M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $2.77M 10-Q · filed 2026-05-14 | $8.59M derived: sum of 2 quarters · filed 2026-05-14 | $12.88M derived: sum of 3 quarters · filed 2026-05-14 | $16.01M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $5.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $10.11M derived: sum of 2 quarters · filed 2026-03-31 | $13.24M derived: sum of 3 quarters · filed 2026-03-31 | $16.16M 10-K · filed 2026-03-31 |
| 2024-09-30 | $4.29M 10-Q · filed 2025-11-13 | $7.42M derived: sum of 2 quarters · filed 2025-11-13 | $10.34M 10-Q · filed 2025-11-13 | $14.74M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $3.13M 10-Q · filed 2025-08-14 | $6.05M 10-Q · filed 2025-08-14 | $10.46M derived: sum of 3 quarters · filed 2025-08-14 | $13.60M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $2.92M 10-Q · filed 2025-05-08 | $7.32M derived: sum of 2 quarters · filed 2025-05-08 | $10.47M derived: sum of 3 quarters · filed 2025-05-08 | $14.18M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $7.55M derived: sum of 2 quarters · filed 2025-03-27 | $11.27M derived: sum of 3 quarters · filed 2025-03-27 | $14.28M 10-K · filed 2025-03-27 |
| 2023-09-30 | $3.15M 10-Q · filed 2024-11-07 | $6.86M derived: sum of 2 quarters · filed 2024-11-07 | $9.88M 10-Q · filed 2024-11-07 | $15.13M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $3.71M 10-Q · filed 2024-08-08 | $6.73M 10-Q · filed 2024-08-08 | $11.98M derived: sum of 3 quarters · filed 2024-08-08 | $15.60M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $3.01M 10-Q · filed 2024-05-09 | $8.26M derived: sum of 2 quarters · filed 2024-05-09 | $11.89M derived: sum of 3 quarters · filed 2024-05-09 | $14.35M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $5.25M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $8.87M derived: sum of 2 quarters · filed 2024-03-14 | $11.34M derived: sum of 3 quarters · filed 2024-03-14 | $14.26M 10-K · filed 2024-03-14 |
| 2022-09-30 | $3.62M 10-Q · filed 2023-11-09 | $6.09M derived: sum of 2 quarters · filed 2023-11-09 | $9.01M 10-Q · filed 2023-11-09 | $12.24M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $2.47M 10-Q · filed 2023-08-10 | $5.39M 10-Q · filed 2023-08-10 | $8.62M derived: sum of 3 quarters · filed 2023-08-10 | $11.54M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $2.92M 10-Q · filed 2023-05-11 | $6.15M derived: sum of 2 quarters · filed 2023-05-11 | $9.07M derived: sum of 3 quarters · filed 2023-05-11 | $11.54M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $3.23M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $6.15M derived: sum of 2 quarters · filed 2023-03-16 | $8.61M derived: sum of 3 quarters · filed 2023-03-16 | $11.55M 10-K · filed 2023-03-16 |
| 2021-09-30 | $2.92M 10-Q · filed 2022-11-10 | $5.39M derived: sum of 2 quarters · filed 2022-11-10 | $8.32M 10-Q · filed 2022-11-10 | $10.75M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $2.47M 10-Q · filed 2022-08-11 | $5.40M 10-Q · filed 2022-08-11 | $7.83M derived: sum of 3 quarters · filed 2022-08-11 | $10.03M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $2.94M 10-Q · filed 2022-05-12 | $5.36M derived: sum of 2 quarters · filed 2022-05-12 | $7.56M derived: sum of 3 quarters · filed 2022-05-12 | $9.75M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $2.42M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $4.63M derived: sum of 2 quarters · filed 2022-03-24 | $6.82M derived: sum of 3 quarters · filed 2022-03-24 | $8.28M 10-K · filed 2022-03-24 |
| 2020-09-30 | $2.20M 10-Q · filed 2021-11-12 | $4.39M derived: sum of 2 quarters · filed 2021-11-12 | $5.85M 10-Q · filed 2021-11-12 | $6.84M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $2.19M 10-Q · filed 2021-08-12 | $3.65M 10-Q · filed 2021-08-12 | $4.64M derived: sum of 3 quarters · filed 2021-08-12 | $5.70M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $1.46M 10-Q · filed 2021-05-13 | $2.45M derived: sum of 2 quarters · filed 2021-05-13 | $3.51M derived: sum of 3 quarters · filed 2021-05-13 | $4.32M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $988.38K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $2.05M derived: sum of 2 quarters · filed 2021-03-25 | $2.86M derived: sum of 3 quarters · filed 2021-03-25 | $3.50M 10-K · filed 2021-03-25 |
| 2019-09-30 | $1.06M 10-Q · filed 2020-11-16 | $1.87M derived: sum of 2 quarters · filed 2020-11-16 | $2.51M 10-Q · filed 2020-11-16 | $3.20M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $807.77K 10-Q/A · filed 2020-11-03 | $1.45M 10-Q/A · filed 2020-11-03 | $2.14M derived: sum of 3 quarters · filed 2020-11-03 | $3.29M derived: sum of 4 quarters · filed 2020-11-03 |
| 2019-03-31 | $640.36K 10-Q · filed 2020-05-14 | $1.33M derived: sum of 2 quarters · filed 2020-05-14 | $2.48M derived: sum of 3 quarters · filed 2020-05-14 | $3.33M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $689.90K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $1.84M derived: sum of 2 quarters · filed 2020-03-30 | $2.69M derived: sum of 3 quarters · filed 2020-03-30 | $3.57M 10-K · filed 2020-03-30 |
| 2018-09-30 | $1.15M 10-Q · filed 2019-11-12 | $2.00M derived: sum of 2 quarters · filed 2019-11-12 | $2.88M 10-Q · filed 2019-11-12 | $3.96M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $848.67K 10-Q · filed 2019-08-14 | $1.73M 10-Q · filed 2019-08-14 | $2.81M derived: sum of 3 quarters · filed 2019-08-14 | $4.22M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $882.05K 10-Q · filed 2019-05-14 | $1.96M derived: sum of 2 quarters · filed 2019-05-14 | $3.37M derived: sum of 3 quarters · filed 2019-05-14 | $3.75M derived: sum of 4 quarters · filed 2019-05-14 |
| 2017-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $2.49M derived: sum of 2 quarters · filed 2019-04-01 | $2.87M derived: sum of 3 quarters · filed 2019-04-01 | $3.10M 10-K · filed 2019-04-01 |
| 2017-09-30 | $1.41M 10-Q · filed 2018-11-14 | $1.79M derived: sum of 2 quarters · filed 2018-11-14 | $2.01M 10-Q · filed 2018-11-14 | $2.21M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $381.52K 10-Q · filed 2018-08-10 | $607.26K 10-Q · filed 2018-08-10 | $806.65K derived: sum of 3 quarters · filed 2018-08-10 | $990.01K derived: sum of 4 quarters · filed 2018-08-10 |
| 2017-03-31 | $225.73K 10-Q · filed 2018-05-14 | $425.13K derived: sum of 2 quarters · filed 2018-05-14 | $608.49K derived: sum of 3 quarters · filed 2018-05-14 | $795.39K derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | $199.39K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | $382.75K derived: sum of 2 quarters · filed 2018-03-28 | $569.66K derived: sum of 3 quarters · filed 2018-03-28 | $796.90K 10-K · filed 2018-03-28 |
| 2016-09-30 | $183.36K 10-Q · filed 2017-11-14 | $370.27K derived: sum of 2 quarters · filed 2017-11-14 | $597.50K 10-Q · filed 2017-11-14 | |
| 2016-06-30 | $186.90K 10-Q · filed 2017-08-25 | $414.14K 10-Q · filed 2017-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |